JP2025501765A5 - - Google Patents
Info
- Publication number
- JP2025501765A5 JP2025501765A5 JP2024538381A JP2024538381A JP2025501765A5 JP 2025501765 A5 JP2025501765 A5 JP 2025501765A5 JP 2024538381 A JP2024538381 A JP 2024538381A JP 2024538381 A JP2024538381 A JP 2024538381A JP 2025501765 A5 JP2025501765 A5 JP 2025501765A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- diseases
- cycloalkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021904204A AU2021904204A0 (en) | 2021-12-22 | Bifunctional sulphonamide compounds | |
| AU2021904204 | 2021-12-22 | ||
| PCT/AU2022/051575 WO2023115149A1 (en) | 2021-12-22 | 2022-12-22 | Bifunctional sulphonamide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501765A JP2025501765A (ja) | 2025-01-23 |
| JP2025501765A5 true JP2025501765A5 (https=) | 2025-12-19 |
Family
ID=86900865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538381A Pending JP2025501765A (ja) | 2021-12-22 | 2022-12-22 | 二官能性スルホンアミド化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250074891A1 (https=) |
| EP (1) | EP4452966A4 (https=) |
| JP (1) | JP2025501765A (https=) |
| KR (1) | KR20240151737A (https=) |
| CN (1) | CN119013268A (https=) |
| AU (1) | AU2022420983A1 (https=) |
| CA (1) | CA3241593A1 (https=) |
| MX (1) | MX2024007883A (https=) |
| WO (1) | WO2023115149A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025096550A1 (en) * | 2023-10-31 | 2025-05-08 | Twine Therapeutics, Inc. | Methods of treating cardiomyopathy |
| WO2025155642A1 (en) * | 2024-01-21 | 2025-07-24 | The Regents Of The University Of California | Dcaf16-based covalent handle for the rational design of monovalent degraders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2948544A1 (en) * | 2014-05-15 | 2015-11-19 | Catalyst Therapeutics Pty Ltd | Methods for inhibiting necroptosis |
| CA2976121A1 (en) * | 2015-02-10 | 2016-08-18 | Catalyst Therapeutics Pty Ltd | Inhibitors of necroptosis |
| WO2018192416A1 (en) * | 2017-04-17 | 2018-10-25 | National Institute Of Biological Sciences, Beijing | Treating Male Senescence |
| CN114521196A (zh) * | 2019-09-16 | 2022-05-20 | 诺华股份有限公司 | 双官能团降解剂及其使用方法 |
| DK4168401T3 (da) * | 2020-06-19 | 2026-04-13 | Anaxis Pharma Pty Ltd | Sulfonamidforbindelser |
-
2022
- 2022-12-22 MX MX2024007883A patent/MX2024007883A/es unknown
- 2022-12-22 EP EP22908911.5A patent/EP4452966A4/en active Pending
- 2022-12-22 JP JP2024538381A patent/JP2025501765A/ja active Pending
- 2022-12-22 KR KR1020247024222A patent/KR20240151737A/ko active Pending
- 2022-12-22 CN CN202280091905.7A patent/CN119013268A/zh active Pending
- 2022-12-22 CA CA3241593A patent/CA3241593A1/en active Pending
- 2022-12-22 AU AU2022420983A patent/AU2022420983A1/en active Pending
- 2022-12-22 WO PCT/AU2022/051575 patent/WO2023115149A1/en not_active Ceased
- 2022-12-22 US US18/722,003 patent/US20250074891A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501766A5 (https=) | ||
| JP2025501765A5 (https=) | ||
| JP2023538408A5 (https=) | ||
| JP6861703B2 (ja) | Ｔｇｒ５修飾物質およびその使用方法 | |
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| EP2940019B1 (en) | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR | |
| JP2018529745A5 (https=) | ||
| CN114286818B (zh) | 作为bet抑制剂的杂环化合物 | |
| JP2007528417A5 (https=) | ||
| JP2019514876A5 (https=) | ||
| JP2019514882A5 (https=) | ||
| JP2011510068A5 (https=) | ||
| CN107922377A (zh) | 乙肝病毒组装效应子 | |
| JP2024519496A5 (https=) | ||
| JP2023520924A5 (https=) | ||
| JPH05194397A (ja) | １，２−ジヒドロ−２−オキソピリジン化合物 | |
| JP2007537272A5 (https=) | ||
| JP7245918B2 (ja) | サルササポゲニン構造に基づく誘導体、医薬組成物及びその使用 | |
| JP7159440B2 (ja) | ジカチオン化合物及びその製造方法と使用 | |
| TW201609707A (zh) | 新穎之經取代嘧啶化合物 | |
| JP2025501767A5 (https=) | ||
| JP2024522196A5 (https=) | ||
| JP2021528451A5 (https=) | ||
| WO2024217531A1 (zh) | Cyp11a1抑制剂及其用途 | |
| JP2023515565A5 (https=) |